Clinical Trials Browser

Phase 1/2 × OTHER × darolutamide × Clear all

NCT05272709 2024-05-13

CURATE

Phase 1/2 Recruiting

Triple Negative Breast Neoplasms

NCT04737109 2023-11-13

ADDItion

Phase 1/2 Terminated

6 enrolled 9 charts

Prostatic Neoplasms